Daniel Knight

PhD candidate focusing on DNA aptamers for ALS and Parkinson’s @Carleton_U | Trainee with @NSERC_PROMOTE

[Daniel Knight @_danielknight]

Hey Twitter Peeps!

Please consider helping us raise much needed funds for ALS research in honour of my Dad. In only 2 years we’ve raised nearly $20,000 and want to keep going!

Help awesome people like @ChrisSnowCGY and @bsw5020 get the treatments they deserve.

Link below! ⬇️

[Carleton University @Carleton_U]

As the 2025 season comes to a close, we reflect on the groundbreaking research, innovative leadership and inspiring community achievements that defined this year for Carleton University.

Read the full recap of our top stories of 2025: https://t.co/raF3srL7M1

[Faces Magazine @facesottawa]

🚨 RT & Follow @facesottawa for your chance to win 2 Front Row seats to Game 3 of #GoSensGo vs #LeafsForever

[NHL @NHL]

Singing O Canada loud and proud after winning the #4Nations Face-Off. 🇨🇦

What a feeling.

[Oligonucleotide Therapeutics Society @OTSociety]

Please join us on June 27 for a 2023 Annual Meeting Poster Awardee Spotlight webinar featuring Daniel Knight and Bahareh Hosseinpour from Carleton University.

Register now: https://t.co/HFUCuCLELB

#oligonucleotidetherapeutics #geneticresearch #webinar @_danielknight

[Tammy Moore @temerityTM]

My heart is bursting after visiting Ottawa. @ALSCanada #WalktoEndALS was such a special event today. A giant group hug, & an Ice Bucket Challenge too… everyone came together, united in passion for the cause and a rally cry for a #WorldFreeofALS/MND. Wow. https://t.co/LyJJz94ouw

[ALS/MND Alliance @ALSMNDAlliance]

Bio gen Receives European Commission Approval for QALSODY® (tofersen) https://t.co/VbngL3Nkq3 #ALSMNDWithoutBorders

[Nature Reviews Methods Primers @MethodsPrimers]

DeRosa et al. provide guidance on the experimental design and data analysis of aptamers and considerations for improving reproducibility in experiments
https://t.co/8posDi7a7r

[ALS Canada @ALSCanada]

Thanks to all our riders & generous supporters, the 2023 ALS Canada #RevolutionRide has raised $280,000 and counting!

Gearing up for change & sparking action together, it’s clear the strength & determination the #ALS community brings is the foundation of the event's success! 💜

[Kelsie Snow @kelsieswrites]

Chris has almost no use of his hands and arms but here he is today, mowing the lawn after he got home from work. Where there’s a will …

#SnowyStrong #EndALS

[TSN Hockey @TSNHockey]

Six months after complications from ALS left him on a ventilator, fighting for his life in the intensive care unit of a Calgary hospital, Chris Snow is hard at work in his new increased role in the Flames’ front office.

Story from @salimvalji: https://t.co/yAuqkmT30g

[CTV News @CTVNews]

New non-invasive tool detects early stages of Alzheimer's and Parkinson's https://t.co/q23y8ozzOi

[Daniel Knight @_danielknight]

A historic win for the ALS community. Thank you does not do justice to explain the gratitude felt by patients families. The future looks so much brighter for so many.

[NeurologyLive® @neurology_live]

BREAKING: The @US_FDA has approved tofersen (@biogen/@ionispharma), now marketed as Qalsody, as the first therapy for SOD-1 #ALS, and the fourth for ALS overall.
https://t.co/RZAlyJZQYR

[Carleton University @Carleton_U]

NEW: @CarletonEngDesg and @CarletonScience researchers have created a non-invasive tool that will help detect #Alzheimers and #Parkinsons disease early, using saliva as an indicator. 🧠🔎

[Barack Obama @BarackObama]

I'm incredibly proud and inspired by @BSW5020 and @Sabrevaya, their family, and the movement they've brought together to fight ALS. They've taken an incredibly challenging moment and are driving change. And they're not done yet.

[Kelsie Snow @kelsieswrites]

To be clear, my husband is alive and skating almost 4 years after a doctor diagnosed with an aggressive form of ALS and gave him 6-12 months to live for one reason: Tofersen.

Please pay attention @US_FDA. Tofersen works and it means everything to my family. #ApproveTofersen

[Kelsie Snow @kelsieswrites]

Today, for the first time since last winter, @ChrisSnowCGY put on his skates. He had to get used to a whole new body since the last time he was on the ice — one with 2 almost useless arms — but he did it & told me during this kids v parents game, “This is so fun.” #nevergiveup

[David Taylor @VPResearch_ALS]

Have general questions about ALS or questions about ALS research? You are never more than a week away from someone who wants to help. Office Hours team will be "in office" on Zoom today, and every Friday at 1-2pm Eastern - https://t.co/3jL82QwhNS

[David Taylor @VPResearch_ALS]

Tofersen works. We've known this for years & VALOR provided proof. It is also the MOST important scientific tool we've ever had for all ALS/MND. It represents proof of concept for transformational treatment of everyone with ALS if we have the correct target & hit it early enough.

[Clene Nanomedicine @CleneNano]

$CLNN announces results for #amyotrophiclateralsclerosis #ALS patient function (ALSFRS-R) and ALS disease progression from the most recent 12-month data cut of the OLE of the Phase 2 RESCUE ALS trial in people with early #ALS treated with CNM-Au8®. More at https://t.co/mUw2EXpRPE

[Chemical Institute of Canada @CIC_ChemInst]

This award is presented to an early career chemist as a mark of distinction and recognition for excellence in their work in equity, diversity and inclusion initiatives. Congrats to Dr. Erin M. McConnell of @Carleton_U on being the recipient of this award. https://t.co/zJwiwxiy1Q